These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 9591854

  • 1. Transient-evoked otoacoustic emissions in children after cisplatin chemotherapy.
    Allen GC, Tiu C, Koike K, Ritchey AK, Kurs-Lasky M, Wax MK.
    Otolaryngol Head Neck Surg; 1998 May; 118(5):584-8. PubMed ID: 9591854
    [Abstract] [Full Text] [Related]

  • 2. Evoked otoacoustic emissions--an approach for monitoring cisplatin induced ototoxicity in children.
    Stavroulaki P, Apostolopoulos N, Segas J, Tsakanikos M, Adamopoulos G.
    Int J Pediatr Otorhinolaryngol; 2001 May 31; 59(1):47-57. PubMed ID: 11376818
    [Abstract] [Full Text] [Related]

  • 3. Progressive hearing loss after completion of cisplatin chemotherapy is common and more pronounced in children without spontaneous otoacoustic emissions before chemotherapy.
    Weissenstein A, Deuster D, Knief A, Zehnhoff-Dinnesen AA, Schmidt CM.
    Int J Pediatr Otorhinolaryngol; 2012 Jan 31; 76(1):131-6. PubMed ID: 22104469
    [Abstract] [Full Text] [Related]

  • 4. Effects of changes in dynamic characteristics of the middle ear on transient-evoked otoacoustic emissions.
    Spirić S, Spirić P, Vranjes D, Aleksić A.
    Med Pregl; 2011 Jan 31; 64(9-10):439-42. PubMed ID: 22097107
    [Abstract] [Full Text] [Related]

  • 5. Otoacoustic emissions--an approach for monitoring aminoglycoside induced ototoxicity in children.
    Stavroulaki P, Apostolopoulos N, Dinopoulou D, Vossinakis I, Tsakanikos M, Douniadakis D.
    Int J Pediatr Otorhinolaryngol; 1999 Nov 05; 50(3):177-84. PubMed ID: 10595663
    [Abstract] [Full Text] [Related]

  • 6. The use of transient evoked otoacoustic emissions as a hearing screen following grommet insertion.
    Dale OT, McCann LJ, Thio D, Wells SC, Drysdale AJ.
    J Laryngol Otol; 2011 Jul 05; 125(7):692-5. PubMed ID: 21524331
    [Abstract] [Full Text] [Related]

  • 7. [Hearing loss caused by high dose carboplatin therapy].
    Lautermann J, Adamczyk M, ten Cate WJ, Kloke O.
    Laryngorhinootologie; 1998 Feb 05; 77(2):82-4. PubMed ID: 9555700
    [Abstract] [Full Text] [Related]

  • 8. The effect of treatment with vincristine on transient evoked and distortion product otoacoustic emissions.
    Riga M, Psarommatis I, Korres S, Lyra Ch, Papadeas E, Varvutsi M, Ferekidis E, Apostolopoulos N.
    Int J Pediatr Otorhinolaryngol; 2006 Jun 05; 70(6):1003-8. PubMed ID: 16359737
    [Abstract] [Full Text] [Related]

  • 9. Evoked otoacoustic emissions in infant hearing screening.
    Decreton SJ, Hanssens K, De Sloovere M.
    Int J Pediatr Otorhinolaryngol; 1991 May 05; 21(3):235-47. PubMed ID: 1869377
    [Abstract] [Full Text] [Related]

  • 10. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S.
    Laryngorhinootologie; 1996 Dec 05; 75(12):709-18. PubMed ID: 9081275
    [Abstract] [Full Text] [Related]

  • 11. Click- and tone-burst-evoked otoacoustic emissions in normally hearing ears and in ears with high-frequency sensorineural hearing loss.
    Hauser R, Probst R, Löhle E.
    Eur Arch Otorhinolaryngol; 1991 Dec 05; 248(6):345-52. PubMed ID: 1930984
    [Abstract] [Full Text] [Related]

  • 12. Changes in transient-evoked otoacoustic emission levels with negative tympanometric peak pressure in infants and toddlers.
    Prieve BA, Calandruccio L, Fitzgerald T, Mazevski A, Georgantas LM.
    Ear Hear; 2008 Aug 05; 29(4):533-42. PubMed ID: 18469719
    [Abstract] [Full Text] [Related]

  • 13. Changes in otoacoustic emissions and high-frequency hearing thresholds in children and adolescents.
    Groh D, Pelanova J, Jilek M, Popelar J, Kabelka Z, Syka J.
    Hear Res; 2006 Feb 05; 212(1-2):90-8. PubMed ID: 16364580
    [Abstract] [Full Text] [Related]

  • 14. Transient-evoked otoacoustic emissions in a group of professional singers who have normal pure-tone hearing thresholds.
    Hamdan AL, Abouchacra KS, Zeki Al Hazzouri AG, Zaytoun G.
    Ear Hear; 2008 Jun 05; 29(3):360-77. PubMed ID: 18382377
    [Abstract] [Full Text] [Related]

  • 15. Chirp-Evoked Otoacoustic Emissions and Middle Ear Absorbance for Monitoring Ototoxicity in Cystic Fibrosis Patients.
    Garinis AC, Keefe DH, Hunter LL, Fitzpatrick DF, Putterman DB, McMillan GP, Gold JA, Feeney MP.
    Ear Hear; 2018 Jun 05; 39(1):69-84. PubMed ID: 28708814
    [Abstract] [Full Text] [Related]

  • 16. Distortion product otoacoustic emissions: an objective technique for the screening of hearing loss in children treated with platin derivatives.
    Dhooge I, Dhooge C, Geukens S, De Clerck B, De Vel E, Vinck BM.
    Int J Audiol; 2006 Jun 05; 45(6):337-43. PubMed ID: 16777780
    [Abstract] [Full Text] [Related]

  • 17. [Otoacoustic emissions measurements in children during the chemotherapy because of the acute lymphoblastic leukemia].
    Lisowska G, Namysłowski G, Hajduk A, Polok A, Tomaszewska R, Misiołek M.
    Otolaryngol Pol; 2006 Jun 05; 60(3):415-20. PubMed ID: 16989457
    [Abstract] [Full Text] [Related]

  • 18. Otoacoustic emissions: an approach for monitoring aminoglycoside-induced ototoxicity.
    Hotz MA, Harris FP, Probst R.
    Laryngoscope; 1994 Sep 05; 104(9):1130-4. PubMed ID: 8072361
    [Abstract] [Full Text] [Related]

  • 19. Left-right asymmetry in hearing loss following cisplatin therapy in children--the left ear is slightly but significantly more affected.
    Schmidt CM, Knief A, Lagosch AK, Deuster D, am Zehnhoff-Dinnesen A.
    Ear Hear; 2008 Dec 05; 29(6):830-7. PubMed ID: 18772725
    [Abstract] [Full Text] [Related]

  • 20. Auditory steady-state responses to bone conduction stimuli in children with hearing loss.
    Swanepoel de W, Ebrahim S, Friedland P, Swanepoel A, Pottas L.
    Int J Pediatr Otorhinolaryngol; 2008 Dec 05; 72(12):1861-71. PubMed ID: 18963045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.